Breaking News Instant updates and real-time market news.

2020-06-09 06:26:25 VRM Vroom $0.00 / + (+0.00%) 06:26 06/09/20 06/09 06:26 06/09/20 06:26	Vroom 21.25M share IPO priced at $22.00 The deal size was increased to 21.25M shares from 18.75M shares and the deal priced above the $18.00-$21.00 range.Goldman Sachs, BofA, Allen & Co. and Wells Fargo acted as joint book running managers for the offering.	09 Jun

2020-06-09 06:26:25

VRM

Vroom

$0.00 / + (+0.00%)

06:26

06/09/20

06/09

06:26

06/09/20

06:26

Vroom 21.25M share IPO priced at $22.00

The deal size was increased to 21.25M shares from 18.75M shares and the deal priced above the $18.00-$21.00 range.Goldman Sachs, BofA, Allen & Co. and Wells Fargo acted as joint book running managers for the offering.

09
Jun

TODAY'S FREE FLY STORIES

Earnings	Acorda Therapeutics reports Q4 EPS ($2.50), one estimate ($1.48) » 16:05 03/04/21 03/04 16:05 03/04/21 16:05 ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 02/19/21 Acorda Therapeutics chief, business operations officer to depart 01/13/21 Catalent to acquire manufacturing operations from Acorda Therapeutics 01/13/21 Acorda Therapeutics sees Q4 Inbrija net revenue of $9M, Ampyra sales of $25M 01/13/21 Acorda Therapeutics announces corporate restructuring ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 01/13/21 Cowen Acorda Therapeutics price target raised to $35 from $5 at Cowen ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 11/03/20 Acorda Therapeutics backs FY20 AMPYRA net revenue, operating expense views 11/03/20 Acorda Therapeutics reports Q3 EPS (23c), consensus (30c) ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 10/19/20 Fly Intel: After-Hours Movers 16:30 Today Acorda Therapeutics - ACOR ACOR Acorda Therapeutics $6.91 / +0.5 (+7.80%) 02/12/21 Acorda Therapeutics options imply 17.4% move in share price post-earnings 11/16/20 Largest borrow rate increases among liquid names 11/09/20 Largest borrow rate increases among liquid names 11/03/20 Acorda Therapeutics options imply 28.1% move in share price post-earnings
Earnings	Silvercrest Asset reports Q4 adjusted EPS 31c, consensus 36c » 16:05 03/04/21 03/04 16:05 03/04/21 16:05 SAMG Silvercrest Asset $14.94 / +0.22 (+1.49%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events SAMG Silvercrest Asset $14.94 / +0.22 (+1.49%) 12/21/20 Janney Montgomery Scott Silvercrest Asset initiated with a Buy at Janney Montgomery Scott SAMG Silvercrest Asset $14.94 / +0.22 (+1.49%) 11/05/20 Silvercrest Asset reports Q3 adjusted EPS 35c, consensus 32c 03/05/21 Silvercrest Asset - SAMG
Recommendations	Kura Sushi price target raised to $42 from $28 at Stephens » 16:04 03/04/21 03/04 16:04 03/04/21 16:04 KRUS Kura Sushi $32.01 / -2.17 (-6.35%) Stephens analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings KRUS Kura Sushi $32.01 / -2.17 (-6.35%) 03/03/21 BTIG Kura Sushi price target raised to $40 from $22 at BTIG 01/12/21 Craig-Hallum Kura Sushi upgraded to Buy from Hold at Craig-Hallum 11/16/20 Craig-Hallum Kura Sushi price target raised to $17 from $11 at Craig-Hallum 10/06/20 Daiwa Kura Sushi initiated with an Outperform at Daiwa KRUS Kura Sushi $32.01 / -2.17 (-6.35%) 01/11/21 Kura Sushi reports Q1 adjusted EPS (71c), consensus (65c) 11/16/20 Kura Sushi reports Q4 EPS (82c), consensus (58c)
Hot Stocks	Ocular Therapeutix gets FDA acceptance of NDA for Dextenza » 16:04 03/04/21 03/04 16:04 03/04/21 16:04 OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) Ocular Therapeutix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 03/01/21 Ocular Therapeutics says 1st patient dosed in phase 2 clinical trial of OTX-DED 01/20/21 Ocular Therapeutix to present new OTX-TIC data at Glaucoma 360 Forum 12/22/20 Ocular Therapeutix submits Dextenza sNDA to FDA 11/04/20 Ocular Therapeutix receives permanent category I CPT code from AMA OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 02/12/21 Piper Sandler Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler 12/30/20 JMP Securities Ocular Therapeutix price target raised to $30 from $20 at JMP Securities 12/28/20 Fly Intel: Top five analyst calls 12/28/20 H.C. Wainwright Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 11/05/20 Ocular Therapeutix reports Q3 EPS (21c), consensus (24c) 10/07/20 Ocular Therapeutix reports preliminary Q3 revenue $5.8M-$5.9M, consensus $3.91M 16 Dec 14 Oct 20 May OCUL Ocular Therapeutix $17.33 / -0.27 (-1.53%) 12/28/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 03/11/21 Ocular Therapeutix - OCUL
Hot Stocks	CoStar withdraws bid to acquire CoreLogic, ends further acquisition talks » 16:04 03/04/21 03/04 16:04 03/04/21 16:04 CSGP CoStar Group $755.60 / -7.475 (-0.98%) , CLGX CoreLogic $82.23 / -0.58 (-0.70%) CoStar Group (CSGP)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 14:49 Today CoStar to pay RentPath $52M in settlement of break-up fee litigation 06:40 Today CoreLogic board concludes CoStar's updated proposal is not superior 03/01/21 CoreLogic confirms receipt of revised proposal from CoStar 03/01/21 CoStar Group submits revised proposal to acquire CoreLogic for $90.00 per share CLGX CoreLogic $82.23 / -0.58 (-0.70%) 06:40 Today CoreLogic board concludes CoStar's updated proposal is not superior 03/01/21 CoreLogic confirms receipt of revised proposal from CoStar 03/01/21 CoStar Group submits revised proposal to acquire CoreLogic for $90.00 per share 02/18/21 Pentwater takes stake in CoreLogic, nominates its CEO to board CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/04/21 Stephens CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities 11/23/20 Wells Fargo CoStar Group price target raised to $990 from $915 at Wells Fargo 10/28/20 Truist CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist CLGX CoreLogic $82.23 / -0.58 (-0.70%) 02/04/21 Stephens CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens 01/06/21 Wolfe Research CoreLogic downgraded to Underperform from Peer Perform at Wolfe Research 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist 12/01/20 Truist CoreLogic downgraded to Hold from Buy at Truist CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/23/21 CoStar Group sees FY21 EPS $10.83-$11.03, consensus $11.42 02/23/21 CoStar Group sees Q1 EPS $2.33-$2.43, consensus $2.64 02/23/21 CoStar Group reports Q4 EPS $2.85, consensus $2.41 10/27/20 CoStar Group sees FY20 EPS $9.39-$9.49, consensus $9.36 CLGX CoreLogic $82.23 / -0.58 (-0.70%) 03/01/21 CoreLogic reports Q4 adjusted EPS $1.51, consensus $1.17 12/11/20 CoreLogic raises FY21 adjusted EPS view to $4.40-$4.65 from $4.00-$4.20 12/11/20 CoreLogic raises FY20 adjusted EPS view to $4.15-$4.25 from $3.65 10/22/20 CoreLogic sees FY20 results at upper end of guidance range 21 May CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/25/21 CoreLogic asks CoStar for more assurances on antitrust risk, Reuters reports 02/04/21 CoStar studying CoreLogic options, including possible new bid, WSJ says 02/04/21 CoStar considering new bid for CoreLogic, WSJ says 02/04/21 CoreLogic sold to private equity for $80 per share, CNBC's Faber reports CLGX CoreLogic $82.23 / -0.58 (-0.70%) 02/25/21 CoreLogic asks CoStar for more assurances on antitrust risk, Reuters reports 02/04/21 CoStar studying CoreLogic options, including possible new bid, WSJ says 02/04/21 CoStar considering new bid for CoreLogic, WSJ says 02/04/21 CoreLogic sold to private equity for $80 per share, CNBC's Faber reports CSGP CLGX CSGP CoStar Group $755.60 / -7.475 (-0.98%) 02/23/21 Fly Intel: After-Hours Movers 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/16/21 Fly Intel: Pre-market Movers CLGX CoreLogic $82.23 / -0.58 (-0.70%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/16/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday

Earnings	Chiasma reports Q4 EPS (32c), consensus (35c) » 16:03 03/04/21 03/04 16:03 03/04/21 16:03 CHMA Chiasma $3.50 / -0.26 (-6.92%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CHMA Chiasma $3.50 / -0.26 (-6.92%) 01/19/21 Chiasma appoints John Doyle as CFO 01/06/21 Chiasma provides update, sees FY21 operating expenses $80M-90M 11/20/20 Chiasma to host panel on acromegaly, MPOWERED Phase 3 trial results 11/18/20 Chiasma says MPOWERED Phase 3 trial met primary non-inferiority endpoint CHMA Chiasma $3.50 / -0.26 (-6.92%) 03/02/21 H.C. Wainwright Chiasma price target raised to $12 from $10 at H.C. Wainwright 01/11/21 Piper Sandler Chiasma price target lowered to $15 from $19 at Piper Sandler 11/05/20 Piper Sandler Chiasma reports first Mycapssa sales, strong cash balance, says Piper Sandler 08/31/20 Piper Sandler Piper sees strong demand for Chiasma's oral acromegaly therapy CHMA Chiasma $3.50 / -0.26 (-6.92%) 11/05/20 Chiasma reports Q3 EPS (30c), consensus (39c) 01 Jul 17:00 Today Chiasma - CHMA
Earnings	Evofem reports Q4 EPS (50c), consensus (36c) » 16:03 03/04/21 03/04 16:03 03/04/21 16:03 EVFM Evofem $3.31 / -0.28 (-7.80%) Reports Q4 net revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options EVFM Evofem $3.31 / -0.28 (-7.80%) 12/17/20 Evofem says Phase 3 trial of EVO100 'remains firmly on schedule' 12/11/20 Evofem announces Orange Book listing of two U.S. patents for Phexxi 12/03/20 Evofem's Phexxi selected by Department of Veterans Affairs for purchase contract 12/02/20 Evofem awarded contract by Department of Veterans Affairs EVFM Evofem $3.31 / -0.28 (-7.80%) 10/01/20 Stifel Evofem initiated with a Buy at Stifel 08/20/20 Morgan Stanley Evofem initiated with an Equal Weight at Morgan Stanley 08/20/20 Morgan Stanley Evofem initiated with an Equal Weight at Morgan Stanley 08/10/20 Oppenheimer Evofem price target raised to $25 from $18 at Oppenheimer EVFM Evofem $3.31 / -0.28 (-7.80%) 11/09/20 Evofem reports Q3 EPS (37c), consensus (44c) 03 Jun 03/16/21 31st Annual Healthcare Virtual Conference 16:30 Today Evofem - EVFM EVFM Evofem $3.31 / -0.28 (-7.80%) 11/02/20 Largest borrow rate increases among liquid names 10/12/20 Largest borrow rate increases among liquid names 09/25/20 Largest borrow rate increases among liquid names 09/21/20 Largest borrow rate increases among liquid names
Hot Stocks	ViewRay not providing guidance at this time » 16:03 03/04/21 03/04 16:03 03/04/21 16:03 VRAY ViewRay $4.16 / -0.09 (-2.12%) Due to the ongoing impact… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events VRAY ViewRay $4.16 / -0.09 (-2.12%) 02/11/21 Penn State Health acquires second ViewRay MRIdian Linac 01/04/21 ViewRay received five new orders for MRIdian systems in Q4 12/21/20 ViewRay announces Catharina Hospital purchases a MRIdian Linac 11/10/20 ViewRay announces Universitair Ziekenhuis Brussels purchases a MRIdian Linac VRAY ViewRay $4.16 / -0.09 (-2.12%) 01/12/21 Piper Sandler ViewRay price target raised to $7 from $4 at Piper Sandler 01/04/21 Piper Sandler Piper Sandler remains 'positively inclined' on ViewRay after preliminary results 11/06/20 Piper Sandler ViewRay price target raised to $4 from $3.50 at Piper Sandler 10/28/20 Fly Intel: Top five analyst upgrades VRAY ViewRay $4.16 / -0.09 (-2.12%) 16:02 Today ViewRay reports Q4 EPS (18c), consensus (17c) 01/04/21 ViewRay sees FY20 revenue approximately $57M, consensus $49.92M 01/04/21 ViewRay sees Q4 revenue approximately $18M, consensus $10.75M 11/05/20 ViewRay reports Q3 EPS (19c), consensus (17c) 22 Jan 05 Jan VRAY ViewRay $4.16 / -0.09 (-2.12%) 01/05/21 Fly Intel: Pre-market Movers 01/04/21 Fly Intel: After-Hours Movers 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 16:30 Today ViewRay - VRAY 03/23/21 ViewRay - VRAY 03/18/21 ViewRay
Earnings	Qumu sees FY21 revenue roughly $35M, consensus $34.19M » 16:02 03/04/21 03/04 16:02 03/04/21 16:02 QUMU Qumu $7.91 / -0.47 (-5.61%) Qumu provides revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events QUMU Qumu $7.91 / -0.47 (-5.61%) 09:17 Today Qumu appoints Lauren Goldstein as chief revenue officer 02/11/21 Qumu appoints Jennifer Pockell Dimas as Chief Marketing Officer QUMU Qumu $7.91 / -0.47 (-5.61%) 02/12/21 Lake Street Synacor downgraded to Hold from Buy at Lake Street 02/08/21 Fly Intel: Top five analyst initiations 02/08/21 Northland Qumu initiated with an Outperform at Northland 07/15/20 Craig-Hallum Qumu price target raised to $5 from $4 at Craig-Hallum QUMU Qumu $7.91 / -0.47 (-5.61%) 16:02 Today Qumu reports Q4 EPS (29c), consensus (23c) 27 Jan QUMU Qumu $7.91 / -0.47 (-5.61%) 01/25/21 Fly Intel: After-Hours Movers 16:30 Today Qumu - QUMU
Earnings	DermTech reports Q4 EPS (48c), consensus (55c) » 16:02 03/04/21 03/04 16:02 03/04/21 16:02 DMTK DermTech $53.65 / -10.35 (-16.17%) Reports Q4 revenue $2.1M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options DMTK DermTech $53.65 / -10.35 (-16.17%) 02/10/21 DermTech enters into pact with Blue Cross Blue Shield of Texas 01/14/21 DermTech announces PLA study results published 01/12/21 DermTech says genomic patch testing for melanoma recommended by NCCN 01/05/21 DermTech appoints Ray Akhavan as general counsel DMTK DermTech $53.65 / -10.35 (-16.17%) 02/11/21 Lake Street DermTech price target raised to $79 from $52 at Lake Street 01/21/21 Oppenheimer Oppenheimer starts DermTech with Outperform, $53 target 01/21/21 Oppenheimer DermTech initiated with an Outperform at Oppenheimer 01/20/21 Craig-Hallum DermTech price target raised to $49 from $23 at Craig-Hallum DMTK DermTech $53.65 / -10.35 (-16.17%) 11/10/20 DermTech reports Q3 EPS (50c), consensus (55c) 07 Jan DMTK DermTech $53.65 / -10.35 (-16.17%) 01/12/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 03/16/21 31st Annual Healthcare Virtual Conference 16:30 Today DermTech - DMTK DMTK DermTech $53.65 / -10.35 (-16.17%) 02/01/21 Largest borrow rate increases among liquid names 11/25/20 new option listings on November 25th

Earnings	ViewRay reports Q4 EPS (18c), consensus (17c) » 16:02 03/04/21 03/04 16:02 03/04/21 16:02 VRAY ViewRay $4.17 / -0.085 (-2.00%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events VRAY ViewRay $4.17 / -0.085 (-2.00%) 02/11/21 Penn State Health acquires second ViewRay MRIdian Linac 01/04/21 ViewRay received five new orders for MRIdian systems in Q4 12/21/20 ViewRay announces Catharina Hospital purchases a MRIdian Linac 11/10/20 ViewRay announces Universitair Ziekenhuis Brussels purchases a MRIdian Linac VRAY ViewRay $4.17 / -0.085 (-2.00%) 01/12/21 Piper Sandler ViewRay price target raised to $7 from $4 at Piper Sandler 01/04/21 Piper Sandler Piper Sandler remains 'positively inclined' on ViewRay after preliminary results 11/06/20 Piper Sandler ViewRay price target raised to $4 from $3.50 at Piper Sandler 10/28/20 Fly Intel: Top five analyst upgrades VRAY ViewRay $4.17 / -0.085 (-2.00%) 01/04/21 ViewRay sees FY20 revenue approximately $57M, consensus $49.92M 01/04/21 ViewRay sees Q4 revenue approximately $18M, consensus $10.75M 11/05/20 ViewRay reports Q3 EPS (19c), consensus (17c) 22 Jan 05 Jan VRAY ViewRay $4.17 / -0.085 (-2.00%) 01/05/21 Fly Intel: Pre-market Movers 01/04/21 Fly Intel: After-Hours Movers 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 16:30 Today ViewRay - VRAY 03/23/21 ViewRay - VRAY 03/18/21 ViewRay
Earnings	Qumu reports Q4 EPS (29c), consensus (23c) » 16:02 03/04/21 03/04 16:02 03/04/21 16:02 QUMU Qumu $7.91 / -0.47 (-5.61%) Reports Q4 revenue $6.9M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events QUMU Qumu $7.91 / -0.47 (-5.61%) 09:17 Today Qumu appoints Lauren Goldstein as chief revenue officer 02/11/21 Qumu appoints Jennifer Pockell Dimas as Chief Marketing Officer QUMU Qumu $7.91 / -0.47 (-5.61%) 02/12/21 Lake Street Synacor downgraded to Hold from Buy at Lake Street 02/08/21 Fly Intel: Top five analyst initiations 02/08/21 Northland Qumu initiated with an Outperform at Northland 07/15/20 Craig-Hallum Qumu price target raised to $5 from $4 at Craig-Hallum 27 Jan QUMU Qumu $7.91 / -0.47 (-5.61%) 01/25/21 Fly Intel: After-Hours Movers 16:30 Today Qumu - QUMU
Periodicals	Fox CEO says no deal with NFL imminent, Bloomberg reports » 15:56 03/04/21 03/04 15:56 03/04/21 15:56 FOXA Fox Corp. $39.00 / -0.32 (-0.81%) , FOX Fox Corp. $36.68 / -0.45 (-1.21%) Fox Corp. CEO Lachlan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FOXA FOX FOXA Fox Corp. $39.00 / -0.32 (-0.81%) 02/09/21 Fox Corp. signs Fox News CEO Suzanne Scott to a new multi-year contract 02/09/21 Fox Corp. signs Suzanne Scott to new multi-year contract 02/09/21 Fox Corp. jumps 5% to $34.26 after Q2 results beat expectations 02/09/21 FOX NOW, FOX Nation now available on VIZIO SmartCast platform FOX Fox Corp. $36.68 / -0.45 (-1.21%) 02/09/21 Fox Corp. signs Fox News CEO Suzanne Scott to a new multi-year contract 02/09/21 Fox Corp. signs Suzanne Scott to new multi-year contract 02/09/21 Fox Corp. jumps 5% to $34.26 after Q2 results beat expectations 02/09/21 FOX NOW, FOX Nation now available on VIZIO SmartCast platform FOXA FOX FOXA Fox Corp. $39.00 / -0.32 (-0.81%) 02/11/21 Citi Fox Corp. price target raised to $33 from $28 at Citi 02/08/21 Morgan Stanley Fox Corp. target raised to $36 at Morgan Stanley after hypothetical LBO exercise 02/08/21 RBC Capital Fox Corp. price target raised to $36 from $31 at RBC Capital 01/28/21 Macquarie Fox Corp. price target raised to $33 from $27 at Macquarie FOX Fox Corp. $36.68 / -0.45 (-1.21%) 10/30/20 Morgan Stanley Morgan Stanley says ad recovery lifts outlook for Fox Corp. 07/15/20 Guggenheim Fox Corp. price target lowered to $29 from $32 at Guggenheim 05/28/20 Jefferies Flutter Entertainment share sale a 'confident, proactive step,' says Jefferies 04/13/20 Citi Fox Corp. resumed with a Neutral at Citi FOXA FOX FOXA Fox Corp. $39.00 / -0.32 (-0.81%) 02/09/21 Fox Corp. reports Q2 adjusted EPS 16c, consensus (3c) 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open 11/03/20 Fox Corp. reports Q1 adjusted EPS $1.18, consensus 74c FOX Fox Corp. $36.68 / -0.45 (-1.21%) 02/09/21 Fox Corp. reports Q2 adjusted EPS 16c, consensus (3c) 11/03/20 Fox Corp. reports Q1 adjusted EPS $1.18, consensus 74c FOXA FOX FOXA Fox Corp. $39.00 / -0.32 (-0.81%) 03/03/21 Amazon in talks to carry 'many' exclusive NFL games on Prime Video, WSJ says 03/03/21 Fox Corp. not exploring go-private deal, CNBC's Faber says 02/09/21 Fox seeks to dismiss Smartmatic's $2.7B defamation lawsuit, NY Times reports 11/12/20 Trump aiming to challenge Fox News with own digital media company, Axios says FOX Fox Corp. $36.68 / -0.45 (-1.21%) 02/09/21 Fox seeks to dismiss Smartmatic's $2.7B defamation lawsuit, NY Times reports 11/12/20 Trump aiming to challenge Fox News with own digital media company, Axios says 10/14/20 Amazon reaches deal to stream NFL playoff game, MarketWatch reports FOXA FOX FOXA Fox Corp. $39.00 / -0.32 (-0.81%) 12/09/20 Disney upgrade, Zoom Video downgrade among today's top calls on Wall Street 12/04/20 Bet On It: Michigan clears path for online gambling 11/14/20 Week in review: How Trump's policies moved stocks 11/12/20 Fly Intel: Wall Street's top stories for Thursday FOX Fox Corp. $36.68 / -0.45 (-1.21%) 01/29/21 Bet On It: Collaboration fuels sports betting nationwide 12/04/20 Bet On It: Michigan clears path for online gambling 11/14/20 Week in review: How Trump's policies moved stocks 11/12/20 Fly Intel: Wall Street's top stories for Thursday 03/03/21 Technology, Media & Telecom Virtual Conference FOXA FOX FOXA Fox Corp. $39.00 / -0.32 (-0.81%) 12/24/20 Early notable gainers among liquid option names on December 24th 12/09/20 21st Century Fox put volume heavy and directionally bearish 11/09/20 21st Century Fox put volume heavy and directionally bearish 11/05/20 21st Century Fox put volume heavy and directionally bearish FOX Fox Corp. $36.68 / -0.45 (-1.21%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/24/20 Early notable gainers among liquid option names on December 24th 09/08/20 Early notable gainers among liquid option names on September 8th
Hot Stocks	Points International trading halted, news pending 15:50 03/04/21 03/04 15:50 03/04/21 15:50 PCOM Points International $15.58 / -0.27 (-1.70%) ShowHide Related Items >><< Company News Street Research PCOM Points International $15.58 / -0.27 (-1.70%) 01/21/21 Points International sees Q4 gross profit $8.3M-$8.7M 12/16/20 Points International announces collaboration with Ethiopian Airlines, Amadeus PCOM Points International $15.58 / -0.27 (-1.70%) 07/20/20 Barrington Points International initiated with an Outperform at Barrington 04/16/20 Northland Points International initiated with a Market Perform at Northland 04/15/20 Fly Intel: Top five analyst downgrades 04/15/20 Points International downgraded to Sector Perform from Outperform at RBC Capital
Periodicals	Vista in talks to add two companies to Apollo SPAC, Solera deal, Bloomberg says » 15:49 03/04/21 03/04 15:49 03/04/21 15:49 APSG Apollo Strategic Growth Capital $10.03 / -0.08 (-0.79%) Vista Equity Partners is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals On The Fly APSG Apollo Strategic Growth Capital $10.03 / -0.08 (-0.79%) 15:48 Today Vista in talks to add two companies to Apollo SPAC, Solera deal, Bloomberg says APSG Apollo Strategic Growth Capital $10.03 / -0.08 (-0.79%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings

Periodicals	Harris breaks tie in Senate over $1.9T stimulus package, FT reports » 15:48 03/04/21 03/04 15:48 03/04/21 15:48 SPX S&P 500 $0.00 / + (+0.00%) , SPY SPDR S&P 500 ETF Trust $376.54 / -4.91 (-1.29%) U.S. Vice President… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options Technical Analysis SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges SPY SPDR S&P 500 ETF Trust $376.54 / -4.91 (-1.29%) 09:19 Today Tanger Factory up 25% in pre-market trading amid WallStreetBets mentions 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 02/01/21 Robinhood raises $3.4B to continue investing in customer growth SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPY SPDR S&P 500 ETF Trust $376.54 / -4.91 (-1.29%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPX SPX S&P 500 $0.00 / + (+0.00%) 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 15:23 Today Senate Democrats agree to tweak parts of $1.9T stimulus bill, Bloomberg says 02/28/21 House approves Biden's $1.9T COVID aid, Reuters reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports SPY SPDR S&P 500 ETF Trust $376.54 / -4.91 (-1.29%) 15:23 Today Senate Democrats agree to tweak parts of $1.9T stimulus bill, Bloomberg says 02/28/21 House approves Biden's $1.9T COVID aid, Reuters reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 09:18 Today Overnight activity included 1089 trades in SPX and 51 trades in VIX 03/03/21 Overnight activity included 1756 trades in SPX and 20 trades in VIX 03/02/21 Overnight activity included 719 trades in SPX and 16 trades in VIX 03/01/21 Overnight activity included 1584 trades in SPX and 57 trades in VIX SPY SPDR S&P 500 ETF Trust $376.54 / -4.91 (-1.29%) 11/09/20 Options markets on track for record option volume SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/19/21 On The Fly: Weekly technical notes for S&P 500 02/12/21 On The Fly: Weekly technical notes for S&P 500 02/05/21 On The Fly: Weekly technical notes for S&P 500 SPY SPDR S&P 500 ETF Trust $376.54 / -4.91 (-1.29%) 08:21 Today SPDR S&P 500 ETF Trust: Pivot points 03/03/21 SPDR S&P 500 ETF Trust: Pivot points 03/02/21 SPDR S&P 500 ETF Trust: Pivot points 03/01/21 SPDR S&P 500 ETF Trust: Pivot points
Hot Stocks	Dominion CEO Blue buys almost $1M in company shares » 15:46 03/04/21 03/04 15:46 03/04/21 15:46 D Dominion $68.04 / -0.34 (-0.50%) Dominion CEO Robert Blue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events D Dominion $68.04 / -0.34 (-0.50%) 02/28/21 Fly Intel: Top five weekend stock stories 01/19/21 Dominion acquires Hardin solar generating facility from Invenergy 01/15/21 Charah Solutions awarded marketing contract by Dominion for 8.1M tons of ash 12/18/20 Dominion announces filing with BOEM for Coastal Virginia Offshore Wind project D Dominion $68.04 / -0.34 (-0.50%) 01/29/21 Mizuho Dominion price target raised to $76 from $75 at Mizuho 01/26/21 Fly Intel: Top five analyst upgrades 01/26/21 Wells Fargo Dominion upgraded to Overweight from Equal Weight at Wells Fargo 01/21/21 Evercore ISI Dominion upgraded to Outperform from In Line at Evercore ISI D Dominion $68.04 / -0.34 (-0.50%) 02/12/21 Dominion sees Q1 operating EPS $1.00-$1.15, consensus 99c 02/12/21 Dominion sees FY21 operating EPS $3.70-$4.00, consensus $3.88 02/12/21 Dominion reports Q4 operating EPS 81c, consensus 80c 02/11/21 Notable companies reporting before tomorrow's open D Dominion $68.04 / -0.34 (-0.50%) 02/27/21 Utilities offer yield, a way to play green energy, Barron's says 12/12/20 Dominion's dividend cut 'a lesson in the danger of high debt,' Barron's says 05/05/21 Dominion Energy Inc
Options	Deutsche Bank call volume above normal and directionally bullish » 15:45 03/04/21 03/04 15:45 03/04/21 15:45 DB Deutsche Bank $12.33 / -0.5 (-3.90%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DB Deutsche Bank $12.33 / -0.5 (-3.90%) 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/04/20 Deutsche Bank, Google Cloud enter multi-year partnership 10/28/20 Deutsche Bank still sees FY20 provision for credit losses 35-45bps of loans DB Deutsche Bank $12.33 / -0.5 (-3.90%) 02/23/21 JPMorgan Deutsche Bank price target raised to EUR 9.60 from EUR 9 at JPMorgan 02/22/21 Berenberg Deutsche Bank price target raised to EUR 7 from EUR 5 at Berenberg 02/22/21 Barclays Barclays upgrades Deutsche Bank to Equal Weight on SPAC opportunity 02/22/21 Barclays Deutsche Bank upgraded to Equal Weight from Underweight at Barclays DB Deutsche Bank $12.33 / -0.5 (-3.90%) 02/04/21 Deutsche Bank reports Q4 group profit EUR 189M vs. (EUR 1.5B) last year 10/28/20 Deutsche Bank reports Q3 profit of EUR 309M, profit before tax EUR 482M DB Deutsche Bank $12.33 / -0.5 (-3.90%) 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 03/01/21 Deutsche Bank under pressure over sale of derivatives products in Spain, FT says 01/24/21 Deutsche starts probe in relation to engagement with some clients, FT says 01/12/21 Deutsche Bank won't do future business with Trump, NY Times reports DB Deutsche Bank $12.33 / -0.5 (-3.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 11/07/20 Week in review: How Trump's policies moved stocks 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday DB Deutsche Bank $12.33 / -0.5 (-3.90%) 03/03/21 Deutsche Bank call volume above normal and directionally bullish 10/29/20 Deutsche Bank put volume heavy and directionally bearish 10/26/20 Deutsche Bank call volume above normal and directionally bullish 10/26/20 Unusually active option classes on open October 26th
Options	T2 Biosystems options imply 26.4% move in share price post-earnings » 15:34 03/04/21 03/04 15:34 03/04/21 15:34 TTOO T2 Biosystems $1.94 / -0.1 (-4.91%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TTOO T2 Biosystems $1.94 / -0.1 (-4.91%) 02/04/21 T2 Biosystems T2SARS-CoV can detect Brazil P.1 variant SARS-CoV 2 virus 01/11/21 T2 Biosystems: T2SARS-CoV-2 Panel can detect multiple variants of COVID-19 01/07/21 T2 Biosystems appoints Aparna Ahuja as CMO 10/19/20 Sepsis Alliance elects T2 Biosystems CEO as board member TTOO T2 Biosystems $1.94 / -0.1 (-4.91%) 01/27/21 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 11/05/20 Alliance Global Partners T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global 10/07/20 BTIG T2 Biosystems initiated with a Buy at BTIG 09/30/20 JonesTrading JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract TTOO T2 Biosystems $1.94 / -0.1 (-4.91%) 01/26/21 T2 Biosystems sees FY20 revenue $18.1M, consensus $19.32M 01/26/21 T2 Biosystems sees Q4 revenue $7.8M, consensus $9.01M TTOO T2 Biosystems $1.94 / -0.1 (-4.91%) 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers 16:30 Today T2 Biosystems - TTOO TTOO T2 Biosystems $1.94 / -0.1 (-4.91%) 02/10/21 Largest borrow rate increases among liquid names 01/12/21 Unusually active option classes on open January 12th 10/06/20 Largest borrow rate increases among liquid names 10/02/20 Largest borrow rate increases among liquid names
Conference/Events	Morgan Stanley LatAm agribusiness analyst has analy st/industry conference call » 15:31 03/04/21 03/04 15:31 03/04/21 15:31 LatAm Agribusiness… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Conference/Events	Morgan Stanley build/construction analyst holds analyst/industry conference call » 15:23 03/04/21 03/04 15:23 03/04/21 15:23 Building &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Periodicals	Senate Democrats agree to tweak parts of $1.9T stimulus bill, Bloomberg says » 15:23 03/04/21 03/04 15:23 03/04/21 15:23 SPX S&P 500 $0.00 / + (+0.00%) , SPY SPDR S&P 500 ETF Trust $376.24 / -5.21 (-1.37%) Senate Democrats have… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options Technical Analysis SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges SPY SPDR S&P 500 ETF Trust $376.24 / -5.21 (-1.37%) 09:19 Today Tanger Factory up 25% in pre-market trading amid WallStreetBets mentions 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 02/01/21 Robinhood raises $3.4B to continue investing in customer growth SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPY SPDR S&P 500 ETF Trust $376.24 / -5.21 (-1.37%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPX SPX S&P 500 $0.00 / + (+0.00%) 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 02/28/21 House approves Biden's $1.9T COVID aid, Reuters reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says SPY SPDR S&P 500 ETF Trust $376.24 / -5.21 (-1.37%) 02/28/21 House approves Biden's $1.9T COVID aid, Reuters reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 09:18 Today Overnight activity included 1089 trades in SPX and 51 trades in VIX 03/03/21 Overnight activity included 1756 trades in SPX and 20 trades in VIX 03/02/21 Overnight activity included 719 trades in SPX and 16 trades in VIX 03/01/21 Overnight activity included 1584 trades in SPX and 57 trades in VIX SPY SPDR S&P 500 ETF Trust $376.24 / -5.21 (-1.37%) 11/09/20 Options markets on track for record option volume SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/19/21 On The Fly: Weekly technical notes for S&P 500 02/12/21 On The Fly: Weekly technical notes for S&P 500 02/05/21 On The Fly: Weekly technical notes for S&P 500 SPY SPDR S&P 500 ETF Trust $376.24 / -5.21 (-1.37%) 08:21 Today SPDR S&P 500 ETF Trust: Pivot points 03/03/21 SPDR S&P 500 ETF Trust: Pivot points 03/02/21 SPDR S&P 500 ETF Trust: Pivot points 03/01/21 SPDR S&P 500 ETF Trust: Pivot points
Periodicals	McDonald's dining rooms in Texas, Mississippi to remain closed, Reuters reports » 15:19 03/04/21 03/04 15:19 03/04/21 15:19 MCD McDonald's $203.96 / -1.795 (-0.87%) McDonald's dining… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $203.96 / -1.795 (-0.87%) 03/02/21 McDonald's CEO vows to crack down on sexual harassment in the workplace 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat signs three-year agreement to be McPlant supplier for McDonald's 01/28/21 McDonald's sees FY21 system wide sales growth of low double digits MCD McDonald's $203.96 / -1.795 (-0.87%) 03/02/21 Citi Citi upgrades Beyond Meat to Buy with 'new-found enthusiasm' for long-term story 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/01/21 Citi Citi opens 'Catalyst Watch' on McDonald's into chicken sandwich launch 01/21/21 UBS UBS sees 'golden' risk reward for McDonald's MCD McDonald's $203.96 / -1.795 (-0.87%) 01/28/21 McDonald's reports Q4 non-GAAP EPS $1.70, consensus $1.78 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 11/09/20 McDonald's reports Q3 ex-items EPS $2.22, consensus $1.90 MCD McDonald's $203.96 / -1.795 (-0.87%) 02/28/21 McDonald's considering selling part of Dynamic Yield, Bloomberg reports 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/09/21 Burger King testing loyalty program in five U.S. markets, CNBC reports 02/02/21 Judge rejects former McDonald's CEO's bid to dismiss lawsuit, Reuters reports MCD McDonald's $203.96 / -1.795 (-0.87%) 03/02/21 Citi says buy Beyond Meat, has 'new-found enthusiasm' following partnerships 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: What to watch in Beyond Meat earnings report MCD McDonald's $203.96 / -1.795 (-0.87%) 03/02/21 Unusually active option classes on open March 2nd 09/09/20 Unusually active option classes on open September 9th
Technical Analysis	NASDAQ market internals summary » 15:17 03/04/21 03/04 15:17 03/04/21 15:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary
Conference/Events	Morgan Stanley US fixed income analyst holds an analyst/industry conference call » 15:16 03/04/21 03/04 15:16 03/04/21 15:16 Head of US Fixed Income… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 16:30

Fed Balance Sheet Level: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Total Assets W/W: Week 3/3/21 Government Event
Today at 16:30

Fed Balance Sheet Reserve Bank Credit W/W: Week 3/3/21 Government Event
ISDR
Today at 16:30

Issuer Direct - ISDR Conference Calls
SDC
Today at 16:30

SmileDirectClub - SDC Conference Calls
TTOO
Today at 16:30

T2 Biosystems - TTOO Conference Calls
JAMF
Today at 16:30

Jamf Holding - JAMF Conference Calls
DMTK
Today at 16:30

DermTech - DMTK Conference Calls
DRRX
Today at 16:30

Durect - DRRX Conference Calls
MDLA
Today at 16:30

Medallia - MDLA Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital $149.49 7M Shares
Fri	No deals

View All Syndicate Announcements »

Vroom 21.25M share IPO priced at $22.00

TODAY'S FREE FLY STORIES

Get Full Fly Access